查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2067603

美國遠端醫療監測市場規模、佔有率和趨勢分析報告：按部署類型、監測類型、最終用途和細分市場預測（2026-2033 年）

U.S. Remote Therapeutic Monitoring Market Size, Share & Trends Analysis Report By Deployment Mode, By Monitoring Type, By End Use, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

美國遠端醫療監測市場概覽

2025年美國遠端醫療監測市場規模估計為4.393億美元，預計到2033年將達到16.782億美元。

預計從 2026 年到 2033 年，該市場將以 18.74% 的複合年成長率成長。肌肉骨骼疾病的日益普遍、穿戴式和行動醫療設備的技術進步以及對遠端醫療和遠端保健解決方案的需求不斷成長，正在推動市場成長。

此外，人工智慧驅動的遠端醫療監測（RTM）平台利用先進的數據分析、機器學習和即時回饋，實現對患者治療進展的更準確、更有效率、更個人化的監測。

以下章節概述了關鍵市場促進因素，包括慢性病盛行率的上升以及影響遠端醫療監測市場的趨勢。此外，還包括對潛在成本降低措施以及支持市場成長的保險和報銷政策的探討。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：美國遠端醫療監測市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 市場機會分析
  • 市場挑戰分析
  • 美國遠端醫療監測市場分析工具
  • 用例研究
  • EHR 整合 RTM 解決方案
  • 法律規範

第4章：美國遠端醫療監測市場：按部署模式分類的估算與趨勢分析

  • 美國遠端醫療監測市場：按部署模式分類的波動分析
  • 美國遠端醫療監測市場：按部署模式分類的規模和趨勢分析（2021-2033年）
  • 基於雲端和網路的
  • 現場

第5章：美國遠端醫療監測市場：按監測類型分類的估算與趨勢分析

  • 美國遠端醫療監測市場：按監測類型分類的波動分析
  • 美國遠端醫療監測市場：按監測類型分類的規模和趨勢分析，2021-2033年
  • 治療數據
  • 非生理數據

第6章：美國遠端醫療監測市場：依最終用途分類的估算與趨勢分析

  • 美國遠端醫療監測市場：按最終用途分類的波動分析
  • 美國遠端醫療監測市場：按最終用途分類的規模和趨勢分析（2021-2033年）
  • 醫療服務提供方
  • 家庭醫療保健
  • 患者和看護者
  • 付款人

第7章 競爭情勢

  • 公司和競爭對手的分類
  • 策略規劃
  • 2025年公司市場分析
  • 公司簡介列表
    • Zimmer Biomet
    • Medsien, Inc.
    • Adhere+Corporation
    • Academy Medtech Ventures
    • CircleLink Health Inc.
    • Limber Health, Inc.
    • HealthArc
    • Hero Health, Inc.
    • Paindrainer AB
    • Physitrack
    • KangarooHealth
    • Spry Therapeutics Inc.
    • WebExercises
    • Blue Marble Health
    • MovementRX（Functional Dimensions LLC）
    • HealthViewX
    • OneStep.
    • IncludeHealth Inc
    • Force
    • Propeller Health（ResMed）
Product Code: GVR-4-68040-537-2

U.S. Remote Therapeutic Monitoring Market Summary

The U.S. remote therapeutic monitoring market size was estimated at USD 439.3 million in 2025 and is projected to reach USD 1,678.2 million by 2033, growing at a CAGR of 18.74% from 2026 to 2033. The rising prevalence of musculoskeletal disorders, technological advancements in wearables and mobile health devices, and the growing preference for telemedicine and telehealth solutions are factors driving market growth.

In addition, artificial intelligence (AI) supported remote therapeutic monitoring (RTM) platforms enable more accurate, efficient, and personalized monitoring of patients' therapeutic progress by leveraging advanced data analytics, machine learning, and real-time feedback.

The section below outlines key market factors, including the rising prevalence of chronic diseases and trends shaping the remote therapeutic monitoring market. It reflects cost reduction potential, insurance, and reimbursement policies supporting the market growth.

U.S. Remote Therapeutic Monitoring Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. remote therapeutic monitoring market report based on deployment mode, monitoring type, and end use:

  • Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
    • Cloud & Web based
    • On-premise
  • Monitoring Type Outlook (Revenue, USD Million, 2021 - 2033)
    • Therapeutic Data
    • Non-Physiological Data
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
    • Healthcare Providers
    • Home Healthcare
    • Patients & Caregivers
    • Payers

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Deployment Mode
    • 1.2.2. Monitoring Type Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Remote Therapeutic Monitoring (RTM) Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technological Advancements in Wearables and Mobile Health Devices
      • 3.2.1.2. Integration of Artificial Intelligence (AI) and Machine Learning (ML)
      • 3.2.1.3. Growing preference for telemedicine and telehealth solutions
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Data security and privacy concerns
      • 3.2.2.2. High initial implementation costs
  • 3.3. Market Opportunity Analysis
  • 3.4. Market Challenges Analysis
  • 3.5. U.S. Remote Therapeutic Monitoring (RTM) Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
      • 3.5.2.4. Environmental Landscape
      • 3.5.2.5. Legal Landscape
      • 3.5.2.6. Social Landscape
  • 3.6. Case Study
  • 3.7. EHR Integrated RTM Solution
  • 3.8. Regulatory Framework

Chapter 4. U.S. Remote Therapeutic Monitoring (RTM) Market: Deployment Mode Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Remote Therapeutic Monitoring (RTM) Market Deployment Mode Movement Analysis
  • 4.3. U.S. Remote Therapeutic Monitoring (RTM) Market Size & Trend Analysis, by Deployment Mode, 2021 to 2033 (USD Million)
  • 4.4. Cloud & Web-based
    • 4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. On-premise
    • 4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Remote Therapeutic Monitoring (RTM) Market: Monitoring Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Remote Therapeutic Monitoring (RTM) Market Monitoring Type Movement Analysis
  • 5.3. U.S. Remote Therapeutic Monitoring (RTM) Market Size & Trend Analysis, by Monitoring Type, 2021 to 2033 (USD Million)
  • 5.4. Therapeutic Data
    • 5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Non-Physiological Data
    • 5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Remote Therapeutic Monitoring (RTM) Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Remote Therapeutic Monitoring (RTM) Market End Use Movement Analysis
  • 6.3. U.S. Remote Therapeutic Monitoring (RTM) Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Healthcare Providers
    • 6.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Home Healthcare
    • 6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Patients & Caregivers
    • 6.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Payers
    • 6.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2025
  • 7.4. Company Profiles/Listing
    • 7.4.1. Zimmer Biomet
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Medsien, Inc.
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Adhere+ Corporation
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Academy Medtech Ventures
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. CircleLink Health Inc.
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Limber Health, Inc.
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. HealthArc
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Hero Health, Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Paindrainer AB
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Physitrack
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. KangarooHealth
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Spry Therapeutics Inc.
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives
    • 7.4.13. WebExercises
      • 7.4.13.1. Company overview
      • 7.4.13.2. Financial performance
      • 7.4.13.3. Product benchmarking
      • 7.4.13.4. Strategic initiatives
    • 7.4.14. Blue Marble Health
      • 7.4.14.1. Company overview
      • 7.4.14.2. Financial performance
      • 7.4.14.3. Product benchmarking
      • 7.4.14.4. Strategic initiatives
    • 7.4.15. MovementRX (Functional Dimensions LLC).
      • 7.4.15.1. Company overview
      • 7.4.15.2. Financial performance
      • 7.4.15.3. Product benchmarking
      • 7.4.15.4. Strategic initiatives
    • 7.4.16. HealthViewX
      • 7.4.16.1. Company overview
      • 7.4.16.2. Financial performance
      • 7.4.16.3. Product benchmarking
      • 7.4.16.4. Strategic initiatives
    • 7.4.17. OneStep.
      • 7.4.17.1. Company overview
      • 7.4.17.2. Financial performance
      • 7.4.17.3. Product benchmarking
      • 7.4.17.4. Strategic initiatives
    • 7.4.18. IncludeHealth Inc,
      • 7.4.18.1. Company overview
      • 7.4.18.2. Financial performance
      • 7.4.18.3. Product benchmarking
      • 7.4.18.4. Strategic initiatives
    • 7.4.19. Force
      • 7.4.19.1. Company overview
      • 7.4.19.2. Financial performance
      • 7.4.19.3. Product benchmarking
      • 7.4.19.4. Strategic initiatives
    • 7.4.20. Propeller Health (ResMed)
      • 7.4.20.1. Company overview
      • 7.4.20.2. Financial performance
      • 7.4.20.3. Product benchmarking
      • 7.4.20.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 List of secondary sources

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 U.S. Remote Therapeutic Monitoring (RTM) Market: Market outlook
  • Fig. 5 U.S. Remote Therapeutic Monitoring (RTM) Market: Segment outlook
  • Fig. 6 U.S. Remote Therapeutic Monitoring (RTM) Market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 U.S. Remote Therapeutic Monitoring (RTM) Market driver impact
  • Fig. 9 U.S. Remote Therapeutic Monitoring (RTM) Market restraint impact
  • Fig. 10 U.S. Remote Therapeutic Monitoring (RTM) Market: Deployment mode outlook and key takeaways
  • Fig. 11 U.S. Remote Therapeutic Monitoring (RTM) Market: Deployment mode movement analysis
  • Fig. 12 Cloud & Web-based market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 13 On-premise market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 U.S. Remote Therapeutic Monitoring (RTM) Market: Monitoring Type outlook and key takeaways
  • Fig. 15 U.S. Remote Therapeutic Monitoring (RTM) Market: Monitoring Type movement analysis
  • Fig. 16 Therapeutic data market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 17 Non-physiological data market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. Remote Therapeutic Monitoring (RTM) Market: End Use outlook and key takeaways
  • Fig. 19 U.S. Remote Therapeutic Monitoring (RTM) Market: End Use movement analysis
  • Fig. 20 Healthcare providers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Home healthcare market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Patients & caregivers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Payers market estimates and forecast, 2021 - 2033 (USD Million)